Correction to: Therapeutic novelties in migraine: new drugs, new hope?

After publication of the original article 1, the authors have notified us that the row corresponding to the "Alniditan" drug shouldn't have been included in Table 1. Table 1 should therefore be presented as below.

Correction to: J Headache Pain (2019) 20:37

https://doi.org/10.1186/s10194-019-0974-3

After publication of the original article [1], the authors have notified us that the row corresponding to the “Alniditan” drug shouldn’t have been included in Table 1. Table 1 should therefore be presented as below:

Table 1

Overview of ditans in alphabetical order

Drug	Status
Lasmiditan (COL-144)	Phase III clinical trials
LY-334370	Development terminated